- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
CannTrust Appoints Financial Advisor for Strategic Review
CannTrust Holdings (NYSE:CTST,TSX:TRST) announced Wednesday (July 31) that it has retained Greenhill & Co. Canada as a financial advisor to assist in a review of strategic alternatives. As quoted in the press release: These alternatives could include, among other things, a sale of the Company or a portion thereof, a strategic investment, a business combination, changes …
CannTrust Holdings (NYSE:CTST,TSX:TRST) announced Wednesday (July 31) that it has retained Greenhill & Co. Canada as a financial advisor to assist in a review of strategic alternatives.
As quoted in the press release:
These alternatives could include, among other things, a sale of the Company or a portion thereof, a strategic investment, a business combination, changes to the Company’s operations or strategy, or continuing to execute on the Company’s current business plan.
There can be no assurance that the Special Committee’s review of strategic alternatives will result in any transaction. The Special Committee has not set a timetable for the conclusion of its review of strategic alternatives and it does not intend to comment further. The nature, timing and outcome of the strategic review process will be influenced by, among other things, the resolution of the Company’s regulatory compliance issues with Heath Canada.
Click here to read the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.